Defects of ferroptosis in tumor-associated M2-macrophages during adverse and recurrent glioblastoma
Ferroptosis and Oxidative Stress · 2025
DOI: 10.70401/fos.2026.0025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ferroptosis and Oxidative Stress, 2025. Verfasst von Christophe Desterke und 7 weiteren Autor:innen. Die Arbeit nennt 66 Literaturangaben.
Abstract (Originalsprache)
Background
Glioblastoma multiforme (GBM) progression relies on active dialog between tumor cells and infiltrating immune cells, mainly including macrophages. Macrophages are closely linked to iron handling and reactive oxygen species (ROS) regulation, suggesting that ferroptosis may play a pivotal role in macrophage behavior.
Method
Bulk RNA-seq GBM datasets, The Cancer Genome Atlas (TCGA)-GBM and gene set enrichment 4412 (GSE4412) were used to quantify immune infiltration (xCell), identify differentially expressed genes (limma), and extract ferroptosis-related markers (FerrDb V2). Ferroptosis-associated transcriptional programs were visualized using the ferroviz R package. Single-cell RNA-sequencing GBM datasets (GSE189650) were processed to characterize ferroptosis-related signatures and explore the dynamic regulation of ferroptosis-related genes in M2 tumor-associated macrophages (M2-TAMs). Deep learning neural networks were trained to predict recurrence based on ferroptosis hallmarks.
Results
High M2-TAM infiltration in poor-prognosis tumors was associated with a deregulated ferroptosis program defined by nine markers, tumor necrosis factor alpha-induced protein 3 (TNFAIP3), arachidonate lipoxygenase 5 (ALOX5), perilipin 2 (PLIN2), spermidine/spermine-N1-acetyltransferase 1(SAT1), ferritin light chain (FTL), cathepsin B (CTSB), poly (ADP-ribose) polymerase 8 (PARP8), heme oxygenase-1 (HMOX1), autophagy-related 7 (ATG7), validated at single-cell resolution and enriched in CD16+/CD163+ myeloid cells. A ferroptosis score independently predicted M2 infiltration in a clinicobiological multivariable model. Deep learning analyses revealed opposite regulation of TNFAIP3 (repressed ferroptosis driver) and FTL (upregulated ferroptosis suppressor) during recurrence, indicating impaired ferroptosis in M2-TAMs during disease progression. TNFAIP3 expression in primary tumors aligned with a pro-inflammatory signature, whereas FTL expression in recurrent tumors correlated with an invasive program involving apolipoprotein E (APO-E), serpin family E member 1 (SERPINE1), thioredoxin-interacting protein (TXNIP), glycoprotein non‑metastatic melanoma protein B (GPNMB), cystatin C (CST3), dihydrofolate reductase (DHFR), β2-microglobulin (B2M), and nuclear protein-1 (NUPR1).
Conclusion
Glioblastoma-associated macrophages display defective ferroptosis program in aggressive and recurrent tumors, linking reduced inflammatory activity to enhanced invasiveness. Restoring ferroptosis activity in these immune cells may represent a promising therapeutic strategy.
Zitieren
APA
Desterke, C., Elhage, R., Fu, Y., Duruel, C., Cresseaux, R., Goffin, V., Chang-Marchand, Y., & Hamaï, A. (2025). Defects of ferroptosis in tumor-associated M2-macrophages during adverse and recurrent glioblastoma. Ferroptosis and Oxidative Stress. https://doi.org/10.70401/fos.2026.0025
Vancouver
Desterke C, Elhage R, Fu Y, Duruel C, Cresseaux R, Goffin V, et al. Defects of ferroptosis in tumor-associated M2-macrophages during adverse and recurrent glioblastoma. Ferroptosis and Oxidative Stress. 2025. doi:10.70401/fos.2026.0025
BibTeX
@article{Desterke2025,
author = {Desterke, Christophe and Elhage, Rima and Fu, Yuanji and Duruel, Clémence and Cresseaux, Rose and Goffin, Vincent and Chang-Marchand, Yunhua and Hamaï, Ahmed},
title = {Defects of ferroptosis in tumor-associated M2-macrophages during adverse and recurrent glioblastoma},
journal = {Ferroptosis and Oxidative Stress},
year = {2025},
doi = {10.70401/fos.2026.0025}
}
EUVIMED